Show simple item record

dc.contributor.authorAssemblée mondiale de la Santé, 52
dc.coverage.spatialGenèveen
dc.date.accessioned2013-06-08T16:04:10Z
dc.date.available2013-06-08T16:04:10Z
dc.date.issued1999
dc.identifier.govdocWHA52.19
dc.identifier.urihttp://www.who.int/iris/handle/10665/84620
dc.descriptionAssemblée mondiale de la Santé, cinquante-deuxième session, Point 13 de l’ordre du jouren
dc.description4 p.en
dc.language.isofren
dc.publisherOrganisation mondiale de la Santéen
dc.subjectPharmaceutical productsen
dc.subjectEssential medicinesen
dc.subjectResolutions and decisionsen
dc.subject.meshPharmaceutical Preparationsen
dc.subject.meshDrug Delivery Systemsen
dc.subject.meshDrug Industryen
dc.subject.meshDrugs, Essentialen
dc.subject.meshPublic Policyen
dc.subject.meshConsumer Health Informationen
dc.titleStratégie pharmaceutique réviséeen
dc.typeGoverning body documentsen
dc.subject.meshqualifierstandardsen
dc.subject.meshqualifierlegislation and jurisprudenceen
dc.subject.meshqualifierorganization and administrationen
dc.subject.meshqualifierethicsen


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record